New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells

New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells

Angelika Długosz-Pokorska,1 Renata Perlikowska,1 Tomasz Janecki,2 Anna Janecka1 1Department of Biomolecular Chemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland; 2Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Lodz, PolandCorrespon...

Full description

Bibliographic Details
Main Authors: Długosz-Pokorska A, Perlikowska R, Janecki T, Janecka A
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:Biologics: Targets & Therapy
Subjects:
mcf-7
mdr
nlp protein
u-359
taxol
tubulin iii
Online Access:https://www.dovepress.com/new-uracil-analog-with-exocyclic-methylidene-group-can-reverse-resista-peer-reviewed-fulltext-article-BTT

Internet

https://www.dovepress.com/new-uracil-analog-with-exocyclic-methylidene-group-can-reverse-resista-peer-reviewed-fulltext-article-BTT

Similar Items